throbber
The EMBO Journal Vol.19 No.7 pp.1731–1742, 2000
`
`DNA polymerase mu (Pol μ), homologous to TdT,
`could act as a DNA mutator in eukaryotic cells
`
`Orlando Domı´nguez, Jose´ F.Ruiz,
`Teresa Laı´n de Lera1, Miguel Garcı´a-Dı´az,
`Manuel A.Gonza´ lez1, Tomas Kirchhoff,
`Carlos Martı´nez-A1, Antonio Bernad1 and
`Luis Blanco2
`
`Centro de Biologı´a Molecular Severo Ochoa (CSIC-UAM) and
`1Departamento de Inmunologı´a y Oncologı´a, Centro Nacional de
`Biotecnologı´a (CSIC), Universidad Auto´noma, 28049 Madrid, Spain
`2Corresponding author
`e-mail: lblanco@cbm.uam.es
`
`O.Domı´nguez and J.F.Ruiz contributed equally to this work
`
`This work is dedicated to the memory of Professor Eladio Vin˜uela
`
`A novel DNA polymerase has been identified in human
`cells. Human DNA polymerase mu (Pol μ), consisting
`of 494 amino acids, has 41% identity to terminal
`deoxynucleotidyltransferase (TdT). Human Pol μ, over-
`produced in Escherichia coli in a soluble form and
`purified to homogeneity, displays intrinsic terminal
`deoxynucleotidyltransferase activity and a strong pref-
`erence for activating Mn2⫹ ions. Interestingly, unlike
`TdT, the catalytic efficiency of polymerization carried
`out by Pol μ was enhanced by the presence of a
`template strand. Using activating Mg2⍣ ions, template-
`enhanced polymerization was also template-directed,
`leading to the preferred insertion of complementary
`nucleotides, although with low discrimination values.
`In the presence of Mn2⍣ ions, template-enhanced poly-
`merization produced a random insertion of nucleotides.
`Northern-blotting and in situ analysis showed a pref-
`erential expression of Pol μ mRNA in peripheral
`lymphoid tissues. Moreover, a large proportion of the
`human expressed sequence tags corresponding to Pol μ,
`present in the databases, derived from germinal center
`B cells. Therefore, Pol μ is a good candidate to be the
`mutator polymerase responsible for somatic hyper-
`mutation of immunoglobulin genes.
`Keywords: human DNA polymerase/mutator/somatic
`hypermutation/terminal deoxynucleotidyltransferase
`
`Introduction
`The maintenance and stability of genetic information in
`DNA depends largely on the high fidelity of DNA synthesis
`displayed by replicative polymerases, which in most cases
`are capable of proofreading insertion errors (reviewed by
`Bebenek and Kunkel, 1995). A further improvement in
`DNA stability relies on different systems of DNA repair,
`able to detect and repair most kinds of DNA damage that,
`if left unrepaired, could lead to cell transformation and
`death. Despite all this DNA maintenance enzymology,
`capable of excising bases and nucleotides, repairing breaks
`
`and correcting mismatches, there is some ‘necessary risk’
`of accumulating DNA mutations as the driving force
`allowing evolution. Such background mutability could be
`due to misfunction of replication and the repair machinery,
`but also to the participation of a specific enzymology,
`contributed by mutator (error-prone) DNA polymerases,
`which should work in opposition to DNA repair.
`DNA polymerase beta (Pol β) is one of the known
`cellular DNA polymerases for which a specific role in
`DNA repair has been proposed (Wilson, 1998; Dianov
`et al., 1999). However, a working hypothesis is that some
`altered versions of Pol β could represent mutator DNA
`polymerases acting as dominant error-prone enzymes
`capable of altering the normal
`levels of DNA repair
`(Bhattacharyya and Banerjee, 1997; Clairmont and
`Sweasy, 1998; Clairmont et al., 1999). Recently, three
`novel non-essential cellular DNA polymerases, zeta (ζ;
`Lawrence and Hinkle, 1996), eta (η; Johnson et al., 1999a)
`and theta (θ; Sharief et al., 1999) have been reported.
`Pol ζ and Pol η are capable of altering the outcome of
`the DNA repair process, since these enzymes are able to
`use damaged (unrepaired) DNA efficiently as a template
`(see Friedberg and Gerlach, 1999). In yeast and fungi,
`most spontaneous and damage-induced mutations are
`introduced by Pol ζ responsible for trans-lesion DNA
`synthesis (Han et al., 1998). A model for somatic hyper-
`mutation of Ig genes has been proposed whereby Pol ζ is
`recruited to the Ig locus (Diaz and Flajnik, 1998). Pol η
`is required for error-free replication of UV lesions, and
`its absence produces the variant (V) form of xeroderma
`pigmentosum, an autosomal recessive disease character-
`ized by a high incidence of skin cancers (Johnson et al.,
`1999b; Masutani et al., 1999). More recently, a novel
`DNA polymerase homologous to Pol β, named Pol lambda
`(λ), has been described and predicted to be involved
`in DNA repair synthesis during meiotic recombination
`(M.Garcı´a-Dı´az, O.Domı´nguez, L.A.Lo´pez-Ferna´ndez,
`T.Laı´n de Lera, M.L.Sanı´ger,
`J.F.Ruiz, M.Pa´rraga,
`M.J.Garcı´a, T.Kirchhoff,
`J.del Mazo, A.Bernad and
`L.Blanco, submitted).
`A clear example of the existence of a particular enzymol-
`ogy for the generation of diversity is the enzyme terminal
`deoxynucleotidyltransferase (TdT), although its action
`appears to be restricted to specific genes such as those
`coding for antigen receptors (reviewed in Bentolila et al.,
`1995). TdT is a DNA-independent DNA polymerase, i.e.
`it has the ability to add nucleotides to DNA without any
`template information. This unusual ability is exploited at
`the broken ends of the V(D)J recombination intermediates
`of rearranging antigen receptor genes. The specificity of
`TdT action on these intermediates depends not only on
`its expression pattern, restricted to primary lymphoid
`organs, but also on specific interactions with the Ku
`protein, the DNA-binding component of DNA-dependent
`
`© European Molecular Biology Organization
`
`1731
`
`Illumina Ex. 1115
`IPR Petition - USP 10,435,742
`
`

`

`O.Domı´nguez et al.
`
`protein kinase (DNA-PK), which functions in DNA repair,
`V(D)J recombination and isotype switching (Mahajan
`et al., 1999). Interestingly, TdT and Pol β are evolutionarily
`related, belonging to the family X of DNA polymerases
`(see Ito and Braithwaite, 1991).
`We describe here the identification and preliminary
`biochemical characterization of a novel human DNA
`polymerase, named DNA polymerase mu (Pol μ), with a
`high similarity to TdT, and whose mRNA is highly
`expressed in secondary lymphoid tissues. The purified
`enzyme exhibited both terminal deoxynucleotidyltransfer-
`ase activity and unprecedented error-proneness on primer–
`template structures. We propose that Pol μ could act as a
`DNA mutator polymerase responsible for the somatic
`hypermutation of immunoglobulin genes.
`
`Results
`Identification of a novel terminal transferase in
`human cells
`The identification and cloning of the complete cDNA
`sequence of the novel human DNA polymerase Pol μ
`belonging to family X was carried out as described in
`Materials and methods. Pol μ is closely related to TdT, a
`member of the Pol X family whose template-independent
`polymerization capacity contributes to generation of
`diversity in antigen receptor genes (reviewed in Bentolila
`et al., 1995). Figure 1 shows a multiple alignment of human
`Pol μ and TdTs from different origins, demonstrating
`an overall amino acid identity of 41%. This value is
`significantly higher than that relating Pol μ and Pol β
`(23%) or Pol β and TdT (22%). A nuclear localization
`signal (NLS) of the most common type (SV40 large
`T antigen) is predicted at
`the sequence ‘PKRRRAR’
`(residues 3–9) of Pol μ. A similar sequence in TdTs was
`proposed to act as an NLS (Bentolila et al., 1995).
`Interestingly, residues 22–120 of Pol μ are predicted (see
`Materials and methods) to form a BRCT domain (Bork
`et al., 1997; Callebaut and Mornon, 1997). This domain,
`whose name derives from its initial identification at the
`C-terminal domain of the BRCA1 protein, is proposed to
`mediate protein–protein interactions in a variety of proteins
`involved in DNA repair and cell cycle checkpoint regula-
`tion upon DNA damage (Bork et al., 1997). As indicated
`in Figure 1, Pol μ residues 141–494 form a conserved
`Pol β core, whose three-dimensional structure in the
`presence of DNA and ddCTP has been solved at high
`resolution (Pelletier et al., 1994). Pol μ shares 139 of the
`209 amino acid residues (66%) that are invariant among
`TdTs from very different origins, implying evolutionarily
`conserved structural and perhaps functional relationships.
`Pol μ also conserves 21 of the 23 amino acid residues
`that are conserved among all members of the hetero-
`geneous Pol X family, including all those residues acting
`as metal, dNTP and DNA ligands, or triggering conforma-
`tional changes upon ternary complex formation (see legend
`to Figure 1; for a review, see Oliveros et al., 1997).
`Therefore, as will be described later, characterization of
`the polymerization activity associated with Pol μ was
`necessary in order to determine whether this TdT homo-
`logue has terminal deoxynucleotidyltransferase activity.
`
`1732
`
`Chromosomal mapping of human Pol μ
`The human gene (POLM) coding for Pol μ was mapped
`initially to chromosome 7 by using a panel of human–
`rodent somatic cell hybrids (see Materials and methods).
`By radiation hybrid analysis (see Materials and methods),
`the SHGC marker that best linked with the POLM gene
`was SHGC-6115, with a lod score of 8.2. Based on the
`correspondence of this marker with the GCK gene, the
`POLM gene has been mapped within band 7p13. This
`region constitutes one of the four known fragile sites in
`lymphocytes, with a high incidence of molecular altera-
`tions such as deletions, inversions and translocations.
`DNA polymerase activity associated with Pol μ
`Human Pol μ was overproduced in Escherichia coli and
`purified to homogeneity as described in Materials and
`methods. The 55 kDa recombinant protein was obtained
`in soluble form in a high yield (see Figure 2A). Taking
`into account that family X DNA polymerases are low
`processive enzymes with no proofreading 3⬘–5⬘ exo-
`nuclease, assay conditions were selected to favour detec-
`tion of a TdT-related enzyme such as Pol μ versus
`endogenous E.coli DNA polymerases. Thus, labelling of
`activated (gapped) heteropolymeric DNA was assayed in
`the presence of a low concentration of dATP as a single
`nucleotide, and activating Mn2⫹ ions. These conditions
`would favour incorporation of complementary and non-
`complementary nucleotide by terminal deoxynucleotidyl-
`transferases (DNA independent), and by low-fidelity DNA-
`dependent DNA polymerases without proofreading activ-
`ity. As shown in Figure 2B, under these conditions, DNA
`labelling with commercial TdT was ~10-fold more efficient
`using Mn2⫹ rather than Mg2⫹ activating ions; on the other
`hand, the opposite metal preference was obtained when
`labelling with the Klenow fragment of E.coli Pol I. As
`shown in Figure 2C, DNA labelling activity was detected
`in the 50% ammonium sulfate precipitate corresponding
`to the Pol μ-induced extracts, but it was very low in
`the corresponding uninduced fraction. Interestingly, the
`catalytic efficiency of the induced DNA polymerase was
`20-fold higher in the presence of Mn2⫹ versus Mg2⫹ ions.
`This induced DNA polymerase activity was co-purified
`with the overproduced 55 kDa polypeptide throughout the
`purification procedure. As a further demonstration that the
`induced DNA polymerase activity was intrinsic to Pol μ,
`the heparin–Sepharose fraction (HS) was sedimented on
`a glycerol gradient. As shown in Figure 3, a DNA
`polymerase activity, preferentially activated by Mn2⫹ ions,
`co-sedimented perfectly at a molecular weight correspond-
`ing to the monomeric form of the Pol μ polypeptide. No
`3⬘–5⬘ exo- or endonucleolytic activities were associated
`with the Pol μ peak (data not shown) and, therefore, the
`glycerol gradient fractions 9 and 10 (pooled) were used
`as the enzyme source for further activity assays.
`Pol μdisplays terminal deoxynucleotidyltransferase
`activity but requires a template–primer structure
`for optimal activity
`In agreement with the structural similarity of Pol μ
`and TdT, a terminal deoxynucleotidyltransferase activity
`associated with Pol μ was demonstrated by using different
`oligonucleotides as single-stranded primer substrates,
`again in the presence of Mn2⫹ as the preferred cation.
`
`

`

`Characterization of human Pol μ
`
`Fig. 1. Pol μ, a novel eukaryotic DNA polymerase homologous to TdT. Multiple alignment of human Pol μ (this study) with TdTs from human (Hs; sp
`P04053), bovine (Bt; sp P06526), murine (Mm; sp P09838), Monodelphis domestica (Md; sp Q02789), chicken (Gd; sp P36195) and Xenopus laevis (Xl;
`sp P42118). Numbers between slashes indicate the amino acid position relative to the N-terminus of each DNA polymerase. A putative nuclear
`localization signal (NLS) at residues 3–9 of human Pol μ is boxed. Amino acid residues 22–118 of Pol μ (boxed) are predicted to form a BRCT domain
`(Bork et al., 1997). Amino acid residues 141–494 of Pol μ (boxed) form a conserved Pol β core (see text for details). Invariant residues between Pol μ and
`TdTs are indicated with white letters (on a black background). Identical residues among TdTs are in bold and boxed (grey). Other relevant similarities
`between Pol μ and TdTs are in bold. Conservative substitutions were considered as follows: K, H and R; D, E, Q and N; W, F, Y, I, L, V, M and A; G, S, T,
`C and P. The 23 residues that are invariant among DNA polymerase X members (Oliveros et al., 1997) are indicated with an asterisk. Dots at the bottom
`of the alignment indicate putative homologues to Pol β residues (Pelletier et al., 1994) shown to act either as DNA ligands (Gly64, Gly66, Gly105,
`Gly109, Lys234, Arg254, Arg283 and Tyr296; grey), or as dNTP and metal ligands (Phe272, Gly274, Arg183; Asp190, Asp192 and Asp256; black).
`Squares at the bottom of the alignment indicate putative homologues to Pol β residues involved in interactions between the ‘palm’ and ‘thumb’
`subdomains (Gly179/Phe272; Arg182/Glu316). The total length, in number of amino acid residues, is indicated in parentheses.
`
`1733
`
`

`

`O.Domı´nguez et al.
`
`Fig. 3. Co-sedimentation of a DNA polymerase activity with the Pol μ
`polypeptide. The heparin–Sepharose fraction (HS) shown in Figure 2A
`was sedimented on a glycerol gradient (15–30%) and fractionated as
`described in Materials and methods. The inset shows an SDS–PAGE
`analysis followed by Coomassie Blue staining of some selected
`fractions. Fractions are numbered from the bottom (1) to the top (22).
`Arrows indicate the sedimentation position of several molecular mass
`markers centrifuged under identical conditions. Quantitation of the
`Pol μ band corresponding to each fraction is expressed in arbitrary
`units of optical density (a.u.; right ordinates). DNA polymerase
`activity ([α-32P]dATP labelling of activated DNA) of each fraction,
`assayed for 15 min at 37°C in the presence of 1 mM MnCl2 (see
`Materials and methods), is expressed as dAMP incorporation (left
`ordinates).
`
`Interestingly, the level of Pol μ-catalysed dTMP incorp-
`oration obtained on single-stranded substrates such as
`oligo(dT) or poly(dA), assayed independently, increased
`up to 370-fold when these were pre-hybridized to form a
`template–primer structure (Figure 4B). On the contrary,
`TdT catalysed a similar incorporation on both single-
`stranded homopolymers and a poly(dA)/oligo(dT) sub-
`strate, in agreement with its template independence (data
`not shown). Therefore, and in spite of its intrinsic terminal
`deoxynucleotidyltransferase activity, Pol μ may be defined
`as a DNA-dependent DNA polymerase, since it requires
`a template–primer for optimal activity.
`Pol μis an error-prone DNA-dependent DNA
`polymerase
`When the polymerization assay on activated DNA (used
`to monitor Pol μ activity during purification) was carried
`out in the presence of all four deoxynucleotides, incorpor-
`ation of the labelled dATP substrate by Pol μ was strongly
`inhibited (Figure 5A). In fact, under the standard conditions
`used to assay most DNA polymerases (⬎100-fold unla-
`belled versus labelled nucleotide precursors), Pol μ activity
`would not be detectable. A similar inhibition was obtained
`with TdT whereas, in the case of the Klenow enzyme, an
`increase (11-fold) in dAMP incorporation was obtained
`by addition of all four nucleotide substrates, as expected.
`Moreover, Pol μ-catalysed dAMP incorporation on
`poly(dT)/oligo(dA) was also inhibited strongly by rela-
`
`Fig. 2. Expression of human Pol μ in Escherichia coli. (A) Coomassie
`Blue staining after SDS–PAGE separation of control non-induced (NI)
`and IPTG-induced (I) extracts of E.coli BL21(DE3) cells transformed
`with the recombinant plasmid pRSET-hPolμ, and further purification
`steps of the latter extracts. The mobility of the induced protein Pol μ
`was compatible with its deduced molecular mass (55 kDa/494 amino
`acids). After PEI precipitation of the DNA, Pol μ was precipitated
`with 50% ammonium sulfate (AS), and purified further by
`phosphocellulose (PC) and heparin–Sepharose (HS) chromatography,
`as described in Materials and methods. The electrophoretic migration
`of a collection of molecular mass markers (MW) is shown at the left.
`(B) Relative activation by Mg2⫹ versus Mn2⫹ of TdT and Klenow
`enzymes during DNA polymerization ([α-32P]dATP labelling) on
`activated DNA. TdT (5 U) and Klenow (1 U) were assayed for 30 min
`at 37°C, in the presence of either 10 mM MgCl2 or 1 mM MnCl2 as a
`source of activating metal ions. DNA polymerase activity, expressed as
`dAMP incorporation, was quantitated as described in Materials and
`methods. (C) DNA polymerization activity associated with Pol μ
`expression. The 50% AS fraction corresponding to either non-induced
`(N.I.) or induced extracts was assayed and quantitated as described in
`(B).
`
`As shown in Figure 4A, Pol μ was able to catalyse
`polymerization of any of the four dNTPs to a single-
`stranded DNA primer in the absence of a template. The
`catalytic efficiency of
`the terminal deoxynucleotidyl-
`transferase activity of Pol μ varied as a function of the
`nucleotide used, dTTP and dCTP (both pyrimidines) being
`inserted the most efficiently, and dATP the least efficiently.
`A different nucleotide preference was observed when
`using TdT, dGTP and dCTP being the preferred nucleotide
`substrates under these conditions. The terminal deoxynu-
`cleotidyltransferase associated with Pol μ was also active,
`although less efficient, on double-stranded DNA substrates
`where the primer terminus was paired with a 5⬘-terminal
`complementary nucleotide (blunt-ended), a behaviour
`already described for TdT (results not shown).
`
`1734
`
`

`

`Characterization of human Pol μ
`
`tively low concentrations of any of the other three (non-
`complementary) nucleotides (Figure 5B). An identical
`behaviour was obtained by using TdT in a parallel assay
`(results not shown). On the contrary, non-complementary
`nucleotides did not inhibit polymerization by the Klenow
`enzyme (see Figure 5B). These results suggest that dAMP
`incorporation by Pol μ is being competed by the other
`nucleotides, as would be expected either for a template-
`independent terminal transferase such as TdT, or for a
`DNA-dependent DNA polymerase with a poor template-
`directed nucleotide discrimination.
`The ability of Pol μ to select among the four
`deoxynucleotides (base discrimination) to catalyse faithful
`template-directed DNA synthesis was evaluated initially
`on the four template–primer structures depicted in Figure 6,
`obtained as described in Materials and methods. The
`four dNTPs, at varying concentrations, were assayed
`individually as a substrate for each of the four template–
`primer structures,
`thus representing the 16 possible
`template–substrate nucleotide pairs (four matched ⫹ 12
`mismatched). The same primer molecule (without any
`template) was assayed in parallel to estimate the residual
`terminal transferase activity of Pol μ with each of the four
`dNTPs. As shown in Figure 6, under the conditions used
`in this experiment, only dTMP was incorporated, with
`either Mg2⫹ or Mn2⫹,
`into the single-stranded DNA
`primer. On the contrary, on the four template–primer
`structures, preferential insertion of the nucleotide comple-
`mentary to the first template base was observed in the
`presence of Mg2⫹ ions, indicating that the catalytic effici-
`ency (Kcat/Km) was improved greatly by template selection
`of the incoming nucleotide (note that the complementary
`nucleotide is provided at a 10-fold lower concentration
`than that used in the control without template). However,
`template instructions appear not to be very rigorous, since
`the enzyme is able to add non-complementary nucleotides
`at 100 μM (dT and dA in Figure 6), and non-complement-
`ary dCTP at higher concentrations (data not shown). The
`probability of G:A misincorporation was estimated to be
`only 10- to 50-fold lower than that of a correct G:C pair
`(data not shown). Considering the efficiency of dTMP
`incorporation on single-stranded DNA, it cannot be ruled
`out
`that
`the observed insertion of dTMP using non-
`complementary templates might be due to residual amounts
`of non-hybridized primer.
`In the presence of Mn2⫹ as metal activator, the pattern
`and efficiency of nucleotide incorporation changed drastic-
`ally (see Figure 6). In all cases, dNTP incorporation was
`driven by the presence of a template DNA (note that the
`nucleotide concentration was 1000-fold lower than that
`used for Mg2⫹ activation), but with a poor or null base
`selectivity. As an example, when dC is the first template
`base, the four dNTPs appear to have similar probabilities
`of being inserted. Exceptionally, dGTP incorporation
`occurred mainly in front of its complementary nucleotide.
`Moreover,
`inserted errors are elongated efficiently,
`favoured not only by complementarity but also as reitera-
`tive misinsertions, particularly when using dTTP and
`dATP substrates. In the same assay, a Pol β-like enzyme
`of only 20 kDa (ASFV Pol X) was shown to extend the
`four template–primer structures by adding only the correct
`(complementary) deoxynucleotide, but not by adding an
`excess (400 μM) of each of the three incorrect (non-
`
`Fig. 4. Pol μ has terminal transferase activity, but requires a template–
`primer structure for optimal efficiency. (A) Terminal transferase
`activity associated with human Pol μ. The assay was carried out as
`described in Materials and methods, using 3.2 nM 5⬘-labelled single-
`stranded 19mer (P19) as substrate, 1 mM MnCl2 as a source of
`activating metal ions, 80 μM each individual deoxynucleotide, and
`either TdT (2.5 U/41 ng) or Pol μ (20 ng). A control reaction in the
`absence of enzyme (C) was also carried out. After incubation for
`30 min at 30°C, extension of the 5⬘-labelled oligonucleotide was
`analysed by 8 M urea–20% PAGE and autoradiography. (B) Template-
`dependent polymerization catalysed by Pol μ. Polymerization
`efficiency was assayed comparatively on either poly(dA) (s),
`oligo(dT) (u) or a poly(dA)/oligo(dT) hybrid (d) to provide a
`homopolymeric template (dA)n. The assay was carried out in the
`presence of 1 mM MnCl2, 13 nM [α-32P]dTTP, Pol μ (20 ng) and
`0.5 μM each DNA substrate. After incubation for the indicated times
`at 37°C, dTMP incorporation was quantitated as described in Materials
`and methods.
`
`

`

`O.Domı´nguez et al.
`
`complementary) deoxynucleotides (Oliveros et al., 1997).
`Similar results were obtained when Mn2⫹ was used instead
`of Mg2⫹ as metal activator (results not shown).
`All these results demonstrate that Pol μ is an error-
`prone DNA-dependent DNA polymerase. Interestingly, in
`the presence of its preferred activator (Mn2⫹), Pol μ
`
`1736
`
`behaves as a strong mutator, lacking base discrimination
`during nucleotide insertion on a DNA template–primer
`structure. Exceptionally, Pol μ preferentially inserts a dG
`in front of its complementary dC template base even in
`the presence of Mn2⫹ ions.
`Pol μmRNA is expressed predominantly in
`peripheral lymphoid tissues
`Quantitative analyses of Pol μ transcription levels in
`different human tissues were carried out by Northern
`blotting using commercial membranes containing normal-
`ized amounts of poly(A)⫹ RNA from different human
`tissues (see Materials and methods). As shown in Figure 7,
`a major transcript migrating at ~2.6 kb, in agreement with
`the size of the cDNA isolated (2589 nucleotides), was
`accumulated at the highest level in lymph nodes, followed
`by spleen, thymus, pancreas and peripheral blood lympho-
`cytes. Lower levels of this transcript were present in the
`other tissues examined, being undetectable only in lung.
`By searching the expressed sequence tag (EST) database
`using Pol μ cDNA, we identified a collection of 40 ESTs
`corresponding to human Pol μ; 37% of these ESTs derive
`from different tumours. It is worth noting that 36% of the
`non-tumoural ESTs of Pol μ derive from human tonsillar
`cells enriched for germinal centre B cells (CD20⫹, IgD–)
`by flow sorting (library NCI-CGAP-GCB1). The signifi-
`cance of this finding is higher considering the fact that
`only 7% of the available ESTs corresponding to Pol β, a
`housekeeping DNA repair polymerase, derive from germ-
`inal centre B cells. All these data suggested that Pol μ
`mRNA could be expressed preferentially in human B
`cells, particularly in populations associated with the germ-
`inal centre structures present
`in secondary lymphoid
`organs. To confirm this suggestion, we used in situ
`hybridization to analyse the localization, at the cellular
`level, of the Pol μ mRNA present in different human
`tissues. Using a specific antisense probe corresponding to
`the first 1200 nucleotides of Pol μ cDNA (see Materials
`and methods), expression of Pol μ mRNA was observed
`in tissue sections corresponding to human secondary
`lymphoid organs. Thus, as shown in Figure 8, and in
`agreement with the data obtained by Northen blotting, the
`stronger signal was found in peripheral
`lymph node
`
`Fig. 5. Inhibition of DNA-directed synthesis by non-complementary
`dNTPs. (A) Inhibition of [α-32P]dATP labelling of activated (gapped)
`DNA by addition of different concentrations of a mixture of dC, dG
`and dTTP, in the presence of 1 mM MnCl2 (a scheme is depicted).
`Under the standard conditions described in Materials and methods,
`only dATP (13 nM) is used as substrate for this assay. After
`incubation for 15 min at 37°C in the presence of either TdT
`(2.5 U/41 ng), Klenow (1 U) or Pol μ (20 ng), and the concentration
`indicated of dNTPs, dAMP incorporation on activated DNA was
`expressed as a percentage of that obtained under standard assay
`conditions: 100% represents either 73 (TdT), 13 (Klenow) or 8 (Pol μ)
`fmol of incorporated dAMP. (B) A similar analysis was carried out,
`but using a poly(dT)/oligo(dA) hybrid to provide a homopolymeric
`template (dT)n. The assay was carried out in the presence of 1 mM
`MnCl2, 13 nM [α-32P]dATP as the correct nucleotide, either 20 ng of
`Pol μ (circles) or 1 U of Klenow (squares), and the concentration
`indicated (on the abscissa) of individual non-complementary dNTPs.
`After 5 min at 37°C, dAMP incorporation on poly(dT)/oligo(dA) was
`expressed as a percentage of that obtained when non-complementary
`nucleotides were added: 100% represents either 23 (Pol μ) or 127
`(Klenow) fmol of incorporated dAMP.
`
`

`

`Characterization of human Pol μ
`
`other human organs such as muscle, lung or even bone
`marrow (the latter shown in Figure 8), a myelo-lymphoid
`tissue, were negative or faintly positive in comparison
`with the corresponding negative control. As shown in
`Figure 8, the level of expression of the Pol μ mRNA in
`lymph nodes seems to be high, in comparison with other
`markers for centroblastic populations such as A-myb (data
`not shown). The in situ hybridization pattern obtained is
`compatible with a preferential expression in the follicular
`lymphoid region, with a variable expression in different
`areas and not restricted to a particular cell subpopulation.
`The expression level of Pol μ mRNA in spleen is lower
`in comparison with that observed in lymph nodes, and
`more restricted to particular structures, such as that shown
`in Figure 8, which resemble the typical organization of a
`germinal centre in a secondary follicular area. Also in this
`case, expression of Pol μ mRNA does not seem to be
`associated preferentially with a discrete cell subpopulation.
`In summary, it seems that Pol μ mRNA is expressed
`preferentially in the follicular areas of human secondary
`lymphoid organs. Therefore, although immunostaining of
`Pol μ in similar tissue sections is still
`lacking,
`it
`is
`tempting to speculate that Pol μ expression could be
`associated with the generation, in these organs, of germinal
`centres, specialized structures that are critical for the
`maturation of the immune humoral response.
`
`Discussion
`The amino acid sequence derived from the Pol μ cDNA
`(a total of 494 amino acids) showed 41% identity with
`TdTs from different origins, suggesting that Pol μ could
`be involved in specific processes such as V(D)J recombina-
`tion of Ig genes, in which TdT contributes to variability
`by adding non-template nucleotides. Interestingly, Pol μ
`contained 21 of the 23 residues that are invariant in all
`DNA polymerases from family X, including all those
`involved in DNA and nucleotide binding, catalysis of
`polymerization and conformational changes involved in
`the polymerization cycle, as defined for Pol β, the para-
`digmal enzyme for DNA polymerase family X. In order
`to delineate the function of Pol μ, we carried out a
`preliminary biochemical characterization of the human
`Pol μ protein overproduced in E.coli, together with expres-
`sion analysis in different tissues at the RNA level.
`Pol μ, a mutator DNA polymerase
`The results presented here demonstrate that Pol μ shares
`enzymatic properties with different members of the Pol X
`family. Like TdT, its closest homologue, Pol μ has an
`intrinsic terminal transferase activity that preferentially
`inserts pyrimidine nucleotides. Thus, its relative nucleotide
`usage, different
`from that observed for TdT,
`is:
`dT⬎⬎dC⬎dG⬎dA. As for Pol β and other DNA-depend-
`ent DNA polymerases, but unlike TdT,
`the catalytic
`efficiency of nucleotide incorporation by Pol μ was greatly
`enhanced by the presence of a template strand. Both
`the terminal
`transferase and DNA-dependent DNA
`polymerization activities of Pol μ are strongly activated
`in vitro by manganese ions. Interestingly, in the presence
`of its preferred activator (Mn2⫹), Pol μ behaves as a
`strong mutator, lacking any base discrimination during
`nucleotide insertion.
`
`1737
`
`Fig. 6. Pol μ-catalysed misinsertion at the four template bases. The
`four template–primer structures used, which differ only in the first
`template base (outlined), are indicated on the left. The single-stranded
`oligonucleotide corresponding to the primer strand was assayed in
`parallel as a control of DNA-independent nucleotide insertion. Mg2⫹-
`activated nucleotide insertion on each 5⬘-labelled DNA substrate
`(3.2 nM) was analysed in the presence of either the complementary
`nucleotide (10 μM) or each of the three incorrect dNTPs (100 μM),
`as described in Materials and methods. Mn2⫹-activated nucleotide
`insertion was assayed with each of the four dNTPs (0.1 μM). After
`incubation for 15 min at 30°C in the presence of 20 ng of human
`Pol μ, extension of the 5⬘-labelled (*) strand was analysed by
`electrophoresis in an 8 M urea–20% polyacrylamide gel and
`autoradiography.
`
`Fig. 7. Pol μ mRNA is expressed preferentially in secondary lymphoid
`organs. Northern blotting analysis of TdT-2 mRNA was carried out as
`indicated in Materials and methods, using commercial blots (MTN and
`MTN-II blots, Clontech) containing poly(A)⫹ RNA from the human
`tissues indicated. The membrane was hybridized with a specific
`32P-labelled DNA probe containing 1141 nucleotides of the Pol μ
`cDNA 3⬘-terminal sequence. The hybridized probe, revealing a major
`transcript (2.6 kb), was detected by autoradiography.
`
`sections; a strong signal was also found in sections from
`spleen. Hybridization specificity was assessed by using a
`sense riboprobe under the same experimental conditions
`and in a close parallel tissue section, not producing a
`comparable signal (see Figure 8). In similar experiments,
`
`

`

`O.Domı´nguez et al.
`
`Fig. 8. In situ hybridization of Pol μ mRNA in different human tissues. DIG-labelled sense and antisense riboprobes, corresponding to the first 1200
`nucleotides of Pol μ cDNA, were obtained and hybridized to human tissue sections (Human Tissue Set I and Human Hematal and Immune Tissue
`Set, Novagen) under the conditions described in Materials and methods. After hybridization, detection of the RNA probes in tissue sections was
`carried out by incubation with anti-DIG–alkaline phosphatase antibody.The dark blue staining, observed in lymph nodes and spleen with the
`antisense riboprobe, outlined regions largely expressing Pol μ mRNA. No comparable signal was obtained by using a sense riboprobe under the
`same experimental conditions and in a close parallel tissue section.
`
`Structural studies demonstrated that two metal ions,
`coordinated by a triad of carboxylate residues, are required
`at

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket